IN VITRO KIDNEY CELL CULTURE FOR NEPHROTOXIN ASSAYS

Information

  • Research Project
  • 3496103
  • ApplicationId
    3496103
  • Core Project Number
    R43DK044059
  • Full Project Number
    1R43DK044059-01A1
  • Serial Number
    44059
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/1/1992 - 32 years ago
  • Project End Date
    8/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    5/1/1992 - 32 years ago
  • Budget End Date
    8/31/1993 - 31 years ago
  • Fiscal Year
    1992
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    4/23/1992 - 32 years ago
Organizations

IN VITRO KIDNEY CELL CULTURE FOR NEPHROTOXIN ASSAYS

Renal ischemia and poisoning of the kidney tubules by toxic agents are major causes of tubular necrosis and acute renal failure. Understanding the mechanism of action of drugs and chemicals on renal cells is important in toxicological screening of drugs as well as the development clinical treatments. The goal of our Phase I research program is to determine the feasibility of using membranes synthesized from extracellular matrix components to improve the growth and differentiated characteristics of kidney cell cultures and to evaluate suitability of these cultures for toxicological testing and mechanistic studies. The defined substrates will be based on collagen-glycosaminoglycan crosslinked copolymers. Two animal species will be studied: rabbit and rat; work will be extended to human cells in Phase II. Successful results will lead to increased longevity and differentiation, permitting better standardization of cultures, longer contact times for agents to be tested, and greater sensitivity and range in observing toxic endpoints. The long term objectives of this study are cultures sufficiently stable in differentiated properties to be shippable to the customer's laboratory as kits for use in drug screening assays, and the validation of cell culture and assay systems for the ability to predict human nephrotoxicity.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R43
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    BIOMAT CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    BELMONT
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02178
  • Organization District
    UNITED STATES